as of 12-05-2025 3:46pm EST
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.
| Founded: | 1984 | Country: | United States |
| Employees: | N/A | City: | PROVO |
| Market Cap: | 603.4M | IPO Year: | 1996 |
| Target Price: | $7.00 | AVG Volume (30 days): | 501.1K |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 2.20 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.32 - $14.62 | Next Earning Date: | 11-06-2025 |
| Revenue: | $1,560,391,000 | Revenue Growth: | -12.10% |
| Revenue Growth (this year): | -12.65% | Revenue Growth (next year): | 2.12% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Chief Product Officer
Avg Cost/Share
$9.61
Shares
5,500
Total Value
$52,855.00
Owned After
167,565
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Hatchett Steven Keith | NUS | Chief Product Officer | Nov 11, 2025 | Buy | $9.61 | 5,500 | $52,855.00 | 167,565 |
See how NUS stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "NUS Nu Skin Enterprises Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.